Nearly 60 organ transplants have been performed after the coronavirus “basically destroyed” patients’ hearts and lungs.
The once-promising therapy that infuses blood plasma from recovered covid-19 patients into newly infected people, theoretically to boost immunity, has suffered setbacks. But some proponents say it’s too early to abandon the treatment.
As experts race to get an approved test for covid variants, officials are severely restricted from sharing information about the cases. That makes it harder to protect others.
El incidente parece ser aislado, el único caso confirmado entre casi 40,000 trasplantes realizados en 2020. Pero ha generado el pedido de que se hagan pruebas más exhaustivas a los donantes.
The first confirmed U.S. case of SARS-CoV-2 being transmitted through an organ transplant has prompted calls for updated transplant protocols and additional testing of samples from deep within donor lungs.
Aunque se definen como “raras”, habría muchas reinfecciones por covid. El problema es que Estados Unidos no tiene la capacidad para hacer el análisis genético necesario para detectarlas.
Hundreds of Americans suspect they contracted covid early in the pandemic and recovered, only to get infected again months later. But because the U.S. does so little genetic sequencing of covid samples, we don’t know much about reinfection rates.
Months after President Donald Trump credited monoclonal antibody therapy for his quick recovery from covid-19, only a trickle of the product has found its way into regular people. While hundreds of thousands of vials sit unused, sick patients who might benefit from early treatment have been left on their own to vie for access.
More than two dozen people who have received the new covid vaccines in U.S. hospitals and health centers suffered anaphylaxis, a potentially fatal allergic reaction. While such severe reactions are rare, experts warn that the drugstores and drive-thru clinics considered integral to the vaccine rollout must be prepared.
Months before federal officials authorized experimental vaccines to ward off the coronavirus in humans, scientists tried a veterinary vaccine in endangered ferrets. Drugmakers are researching similar efforts for other animals proving vulnerable to the virus, such as farmed minks, in part to guard against virus mutations that could pose new risks to people.
Se aconseja a los hospitales que cubran a los miembros de su fuerza laboral con mayor riesgo, pero deben decidir exactamente quiénes serán mientras no haya dosis suficientes.
Even as the federal Food and Drug Administration engaged in intense deliberations ahead of Friday’s authorization of the nation’s first COVID vaccine, and days before the initial doses were to be released, hospitals have been grappling with how to distribute the first scarce shots. Their plans vary broadly.
With two vaccines against coronavirus disease poised for release within weeks, experts say they expect attitudes to shift dramatically from hesitancy to “Beanie Baby”-level urgency.
A proposal in Washington state would use right-to-try laws to allow terminally ill patients access to psilocybin — the famed magic mushrooms of America’s psychedelic ’60s — to ease depression and anxiety.
Dicen que hay que informar a los consumidores, para que se preparen para efectos secundarios que, en realidad, pueden significar que las vacunas funcionan.
From the likelihood of achy, flu-like side effects to the need for two doses, weeks apart, consumers need to know now what to expect when vaccines to prevent COVID-19 roll out.
Mientras resurgen los casos de COVID-19 en los Estados Unidos, científicos y veterinarios investigan el virus en animales domésticos y salvajes. Ya han realizado miles de pruebas.
Thousands of animals in the U.S. have been tested for the coronavirus, as researchers work to understand its transmission and which other species might be at risk. So far, dozens have tested positive, mostly cats and dogs exposed to sick owners.
La Casa Blanca y muchos estadounidenses han depositado sus esperanzas de derrotar a la pandemia en una vacuna. Pero científicos advierten que se espera demasiado, y demasiado pronto.
Some argue that vaccines capable of preventing any COVID-19 symptoms should qualify for widespread use, but others want much larger trials to prove the vaccines can reduce hospitalizations or deaths.